PortalsOS

Dr. Fagenbaum's AI platform has reviewed over 6,000 drug-disease matches, identifying promising treatments hiding in plain sight.

I visited the FDA to ask, you've approved this drug for bladder cancer. You have in the package insert the mechanism of action. It's the only drug in the history of medicine, which is basically your natural protein.

This is a watershed moment. Certainly, this is an enormous moment. This war was blocked for two years. President Biden, who preceded him, was unable to find a way to stop it. President Trump found that way by being tough on both sides.

The Trump administration is accused of dismantling cancer research by cutting funding and terminating employees, which could take decades to recover from.

Three weeks later, I see in the press that Johnson & Johnson is about to get priority review by the agency for chemotherapy in the bladder.

Imagine what those poor families have been through for two years worrying about their loved ones, and now finally finding out that President Trump got this done. It's just what an incredible accomplishment.

It's incongruous to me that you can priority review for chemotherapy and not priority review for a biologic that is safe.

Dr. Fagenbaum's nonprofit aims to ensure that all FDA-approved drugs are used for every disease they can possibly treat.

I said to these two reviewers, senior reviewers, one a female and one a male, they've been here for years and years. If my father had bladder, Why wouldn't I give my father that chance? Response? I don't care.

The FDA refused to file our data for bladder cancer treatment, even though we have patients alive and cancer-free for 10 years. It's mystifying!